Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

NCT02096315 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchiectasis
Lower Respiratory Infection

Interventions

DRUG: POL7080

Sponsor

Polyphor Ltd.